Top stories in health and medicine, June 6, 2013

Brought to you by MedPage Today.

1. Off-Label Chemo Common for Mets. Off-label prescribing of chemotherapy agents is common in the metastatic setting and a substantial proportion of it goes beyond National Comprehensive Cancer Network (NCCN)-accepted practice.

2. FDA Panel Starts to Tackle Avandia Safety. A controversial study of the cardiovascular safety of one-time diabetes blockbuster rosiglitazone (Avandia) has proven difficult for FDA and independent reviewers to reanalyze.

3. Just 1 Doc in 10 Meets Meaningful Use Criteria. More physicians are using electronic health records (EHRs), but a significantly smaller proportion of eligible physicians say they have met the first stage of meaningful use criteria.

Comments are moderated before they are published. Please read the comment policy.

Most Popular